Title : Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells.

Pub. Date : 2017 Jan 17

PMID : 28032592






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Interestingly, lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, blocked the increase of cetuximab-induced HER3 phosphorylation. Lapatinib erb-b2 receptor tyrosine kinase 3 Homo sapiens
2 Additionally, we showed that upon HER3 knockdown, cetuximab combined with lapatinib was able to decrease cell viability compared to HER3 expressing cells. Lapatinib erb-b2 receptor tyrosine kinase 3 Homo sapiens